2003年4月15日 · Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651 J …

2003年4月15日 · Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651. …

Pediatric Oncology Group Study POG-8651 By Allen M. Goorin, Douglas J. Schwartzentruber, Meenakshi Devidas, Mark C. Gebhardt, Alberto G. Ayala, Michael B. Harris, Lee J. Helman, …

Multi‐agent neoadjuvant chemotherapy for eight to 10 weeks before surgery and again with adjuvant chemotherapy for 12 to 29 weeks after surgery are used to treat people with …

(POG–8651) conducted by the Pediatric Oncology Group from 1986 to 1993 compared immediate surgery followed by post-operative chemotherapy versus presurgical chemotherapy followed …

2021年7月29日 · The POG-8651 trial in the USA was designed to demonstrate the superiority of preoperative and post-operative chemotherapy over post-operative chemotherapy alone.

POG-8651 compared surgery followed by adjuvant chemotherapy versus neo-adjuvant chemotherapy followed by surgery. The event-free survival (EFS) was similar in both groups – …

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. Successful …

A. M. Goorin, D. J. Schwartzentruber, M. Devidas, M. C. Gebhardt, A. G. Ayala, M. B. Harris and Pediatric Oncology Group, “Presurgical Chemotherapy Compared with Immediate Surgery and …

Presurgical Chemotherapy compared with immediate surgery and adjuvant Chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651 Author